Adicet Bio, Inc. Insider Trading
ACET
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Jan 2024.
Get an email when ACET's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7 – 8 | Orbimed Advisors Israel II Ltd Large holder | SoldNo plan 4 parts | 104,658 | $6.45 average | 675K | 100% | Form 4 |
| Feb 18 – 20 | RA Capital Healthcare Fund LP Large holder | Bought 3 parts | 223,596 | $7.17 average | $1.6M | 23% | Form 4 |
| Oct 8, 2025 | Orbimed Advisors LLC Large holder | Bought 2 parts | 5,000,000 | $1.00 average | $5M | New | Form 4 |
- Apr 7 – 8No planOrbimed Advisors Israel II LtdLarge holder · sold 104,658 at avg $6.45675K100% of stake
- Feb 18 – 20RA Capital Healthcare Fund LPLarge holder · bought 223,596 at avg $7.17$1.6M23% of stake
- Oct 8, 2025Orbimed Advisors LLCLarge holder · bought 5,000,000 at avg $1.00$5MNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ACET
Spot a number that looks wrong? Check it in ACET's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ACET
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.